Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia

Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2122544119. doi: 10.1073/pnas.2122544119. Epub 2022 May 19.

Abstract

Environmental perturbations during the first years of life are a major factor in psychiatric diseases. Phencyclidine (PCP), a drug of abuse, has psychomimetic effects, and neonatal subchronic administration of PCP in rodents leads to long-term behavioral changes relevant for schizophrenia. The cerebellum is increasingly recognized for its role in diverse cognitive functions. However, little is known about potential cerebellar changes in models of schizophrenia. Here, we analyzed the characteristics of the cerebellum in the neonatal subchronic PCP model. We found that, while the global cerebellar cytoarchitecture and Purkinje cell spontaneous spiking properties are unchanged, climbing fiber/Purkinje cell synaptic connectivity is increased in juvenile mice. Neonatal subchronic administration of PCP is accompanied by increased cFos expression, a marker of neuronal activity, and transient modification of the neuronal surfaceome in the cerebellum. The largest change observed is the overexpression of Ctgf, a gene previously suggested as a biomarker for schizophrenia. This neonatal increase in Ctgf can be reproduced by increasing neuronal activity in the cerebellum during the second postnatal week using chemogenetics. However, it does not lead to increased climbing fiber/Purkinje cell connectivity in juvenile mice, showing the complexity of PCP action. Overall, our study shows that administration of the drug of abuse PCP during the developmental period of intense cerebellar synaptogenesis and circuit remodeling has long-term and specific effects on Purkinje cell connectivity and warrants the search for this type of synaptic changes in psychiatric diseases.

Keywords: cerebellum; development; phencyclidine; schizophrenia; synapse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Connective Tissue Growth Factor / genetics
  • Connective Tissue Growth Factor / metabolism
  • Disease Models, Animal
  • Hallucinogens* / administration & dosage
  • Hallucinogens* / adverse effects
  • Mice
  • Neurons / drug effects
  • Neurons / metabolism
  • Phencyclidine* / administration & dosage
  • Phencyclidine* / adverse effects
  • Proto-Oncogene Proteins c-fos / metabolism
  • Purkinje Cells* / drug effects
  • Purkinje Cells* / physiology
  • Purkinje Cells* / ultrastructure
  • Receptors, Phencyclidine / agonists
  • Schizophrenia* / chemically induced
  • Schizophrenia* / pathology
  • Synapses / drug effects
  • Synapses / ultrastructure

Substances

  • CCN2 protein, mouse
  • Hallucinogens
  • Proto-Oncogene Proteins c-fos
  • Receptors, Phencyclidine
  • Connective Tissue Growth Factor
  • Phencyclidine